These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 6685506)

  • 1. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
    Carmeliet E; Janssen PA; Marsboom R; Van Nueten JM; Xhonneux R
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
    Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M
    Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias.
    Wu KM; Proakis AG; Hunter TL; Shanklin JR
    Arch Int Pharmacodyn Ther; 1989; 301():131-50. PubMed ID: 2624512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
    Gibson JK; Patterson E; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Apr; 237(1):318-25. PubMed ID: 3754279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
    Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
    Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
    Lynch JJ; Wallace AA; Stupienski RF; Baskin EP; Beare CM; Appleby SD; Salata JJ; Jurkiewicz NK; Sanguinetti MC; Stein RB
    J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction.
    Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K
    Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic, antiarrhythmic and hemodynamic effects of transcainide.
    Carmeliet E; Janssen PA; Heykants J; Niemegeers CJ; Remeysen P; Van De Water A; Van Gerven W; Wauquier A; Xhonneux R
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):272-90. PubMed ID: 3632145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
    Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC
    J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate.
    Yorikane R; Mizuno H; Itoh Y; Koike H; Miyake S; Shiga H; Kumakura S; Fukami M; Shimoji Y; Hashimoto T
    Arzneimittelforschung; 1991 Nov; 41(11):1130-6. PubMed ID: 1810258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers.
    Colatsky TJ; Bird LB; Jurkiewicz NK; Wendt RL
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):435-44. PubMed ID: 2438506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indecainide: effects on arrhythmias, electrophysiology, and cardiovascular dynamics.
    Holland DR; Lacefield WB; Gonzales CR; Johnston SR; Turk JA
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):454-61. PubMed ID: 2476626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.